2011

Kapferer I, Schmidt S, Gstir R, Durstberger G, Huber LA, Vietor I: Gene-expression profiles of epithelial cells treated with EMD in vitro: analysis using complementary DNA arrays. J. Periodont. Res 2011, 46:118-125. PMID: 21108644

Nairz M, Schroll A, Moschen AR, Sonnweber T, Theurl M, Theurl I, Taub N, Jamnig C, Neurauter D, Huber LA, Tilg H, Moser PL, Weiss G: Erythropoietin Contrastingly Affects Bacterial Infection and Experimental Colitis by Inhibiting Nuclear Factor-κB-Inducible Immune Pathways. Immunity 2011, 34:61-74. PMID: 21256055

Prokudin I, Stasyk T, Rainer J, Bonn GK, Kofler R, Huber LA: Comprehensive proteomic and transcriptomic characterization of hepatic expression signatures affected in p14 liver conditional knockout mice. Proteomics 2011, 11:469-480. PMID: 21268275

Skvortsov S, Schäfer G, Stasyk T, Fuchsberger C, Bonn GK, Bartsch G, Klocker H, Huber LA: Proteomics profiling of microdissected low- and high-grade prostate tumors identifies lamin a as a discriminatory biomarker. J. Proteome Res 2011, 10:259-268. PMID: 20977276

2010

Huber C, Huber L: Special focus on top-down proteomics. Proteomics 2010, 10:3564-3565 PMID: 20945425.

Huber LA: Do pharmacogenetics, genomics and epigenetics hold promise for molecular therapeutics and health? Curr. Opin. Mol. Ther 2010, 12:268-269 PMID: 20556904.

Morandell S, Grosstessner-Hain K, Roitinger E, Hudecz O, Lindhorst T, Teis D, Wrulich OA, Mazanek M, Taus T, Ueberall F, Mechtler K, Huber LA: QIKS--Quantitative identification of kinase substrates. Proteomics 2010, 10:2015-2025 PMID: 20217869.

Ruemmele FM, Müller T, Schiefermeier N, Ebner HL, Lechner S, Pfaller K, Thöni CE, Goulet O, Lacaille F, Schmitz J, Colomb V, Sauvat F, Revillon Y, Canioni D, Brousse N, de Saint-Basile G, Lefebvre J, Heinz-Erian P, Enninger A, Utermann G, Hess MW, Janecke AR, Huber LA: Loss-of-function of MYO5B is the main cause of microvillus inclusion disease: 15 novel mutations and a CaCo-2 RNAi cell model. Hum. Mutat 2010, 31:544-551 PMID: 20186687.

Schottdorf, P.,: Epithelial-mesenchymal transition and Expression of c-myc are vital for cetumimab-increase dresponse on Radiation in Squamous cell carcinoma. Strahlentherapie und Onkologie 2010:P. 130-131.

Schwarze F, Meraner J, Lechner M, Loidl A, Stasyk T, Laich A, Loidl P: Cell cycle-dependent acetylation of Rb2/p130 in NIH3T3 cells. Oncogene 2010, 29:5755-5760 PMID: 20676144.

Skvortsova I, Skvortsov S, Raju U, Stasyk T, Riesterer O, Schottdorf E-M, Popper B-A, Schiestl B, Eichberger P, Debbage P, Neher A, Bonn GK, Huber LA, Milas L, Lukas P: Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse. Radiother Oncol 2010, 96:108-115 PMID: 20451273.

Soeno Y, Taya Y, Stasyk T, Huber LA, Aoba T, Hüttenhofer A: Identification of novel ribonucleo-protein complexes from the brain-specific snoRNA MBII-52. RNA 2010, 16:1293-1300 PMID: 20484469.

Stasyk T, Holzmann J, Stumberger S, Ebner HL, Hess MW, Bonn GK, Mechtler K, Huber LA: Proteomic analysis of endosomes from genetically modified p14/MP1 mouse embryonic fibroblasts. Proteomics 2010, 10:4117-4127 PMID: 21080497.

Stasyk T, Lutsik-Kordovsky M, Wernstedt C, Antonyuk V, Klyuchivska O, Souchelnytskyi S, Hellman U, Stoika R: A new highly toxic protein isolated from the death cap Amanita phalloides is an L-amino acid oxidase. FEBS J 2010, 277:1260-1269 PMID: 20121947.

Teis D, Saksena S, Judson BL, Emr SD: ESCRT-II coordinates the assembly of ESCRT-III filaments for cargo sorting and multivesicular body vesicle formation. EMBO J 2010, 29:871-883 PMID: 20134403.

Wickström SA, Lange A, Hess MW, Polleux J, Spatz JP, Krüger M, Pfaller K, Lambacher A, Bloch W, Mann M, Huber LA, Fässler R: Integrin-linked kinase controls microtubule dynamics required for plasma membrane targeting of caveolae. Dev. Cell 2010, 19:574-588 PMID: 20951348.

Wickstrom, R.,: Integrin-linked kinase controls microtubule dynamics required for plasma membrane targeting of caveolae. European Journal of Cell Biology 2010:P. 31-31.

Yu C, Jiang S, Lu J, Coughlin CC, Wang Y, Swietlicki EA, Wang L, Vietor I, Huber LA, Cikes D, Coleman T, Xie Y, Semenkovich CF, Davidson NO, Levin MS, Rubin DC: Deletion of Tis7 protects mice from high-fat diet-induced weight gain and blunts the intestinal adaptive response postresection. J. Nutr 2010, 140:1907-1914 PMID: 20861213.

2009

Gu Y, Harley ITW, Henderson LB, Aronow BJ, Vietor I, Huber LA, Harley JB, Kilpatrick JR, Langefeld CD, Williams AH, Jegga AG, Chen J, Wills-Karp M, Arshad SH, Ewart SL, Thio CL, Flick LM, Filippi M-D, Grimes HL, Drumm ML, Cutting GR, Knowles MR, Karp CL: Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease. Nature 2009, 458:1039-1042 PMID: 19242412.

Hutzinger R, Feederle R, Mrazek J, Schiefermeier N, Balwierz PJ, Zavolan M, Polacek N, Delecluse H-J, Hüttenhofer A: Expression and processing of a small nucleolar RNA from the Epstein-Barr virus genome. PLoS Pathog 2009, 5:e1000547 PMID: 19680535.

Skvortsov, P.,: Identification of differential protein expression of radioresistant prostate carcinoma cells. Strahlentherapie und Onkologie 2009:P. 148-149.

Teis D, Saksena S, Emr SD: SnapShot: the ESCRT machinery. Cell 2009, 137:182-182.e1 PMID: 19345195.